NCT00267657Unknown1 期
Assessment of Interactions Between IV Methamphetamine and Reserpine
适应症
相关药物
试验速览
- 阶段
- 1 期
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- CNS norepinephrine turnover
研究概览
简要总结
In this parallel group clinical pharmacology laboratory experiment, we will assess pharmacodynamic interactions (with a focus on cardiovascular effects) of a 15 mg intravenous methamphetamine dose and single oral doses of reserpine (0.5 and 1.0 mg) or placebo.
详细描述
In this parallel group clinical pharmacology laboratory experiment, we will assess pharmacodynamic interactions (with a focus on cardiovascular effects) of a 15 mg intravenous methamphetamine dose and single oral doses of reserpine (0.5 and 1.0 mg) or placebo.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 21 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Please contact site for more details
排除标准
- •Please contact site for more details
结局指标
主要结局
CNS norepinephrine turnover
Cardiovascular
Subjective symptoms/Mood Effects
Craving
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
1 期
Assessment of Interactions Between Methamphetamine and Aripiprazole - 1Amphetamine-Related DisordersNCT00089440National Institute on Drug Abuse (NIDA)17
Unknown
1 期
Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1Amphetamine-Related DisordersNCT00265278National Institute on Drug Abuse (NIDA)16
Unknown
1 期
Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Amphetamine-Related DisordersNCT00033072National Institute on Drug Abuse (NIDA)16
Unknown
1 期
Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1Amphetamine-Related DisordersNCT00040040National Institute on Drug Abuse (NIDA)20
已完成
1 期
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]Methamphetamine Use DisorderNCT04178993Craig Rush8